Literature DB >> 23255895

Concomitant intraductal papillary mucinous neoplasm and neuroendocrine tumor of the pancreas.

Mitsuaki Ishida1, Hisanori Shiomi, Shigeyuki Naka, Tohru Tani, Hidetoshi Okabe.   

Abstract

Intraductal papillary mucinous neoplasm (IPMN) and neuroendocrine tumor (NET) of the pancreas are rare tumors and their association is not expected to be frequent. However, certain studies have suggested that the concomitant occurence of these tumors may be more frequent than previously thought. In the current study, we describe a case of concomitant occurrence of IPMN and NET of the pancreas and review the clinicopathological features of previously published cases and the current one. A 68-year-old female was incidentally found to have dilatation of the main pancreatic duct. A distal pancreatectomy was performed under the clinical diagnosis of IPMN. Histopathological analysis revealed concomitant IPMN (low-grade) and NET G1 of the pancreas. Review of the clinicopathological features of the 15 previously reported cases of concomitant IPMN and NET of the pancreas as well as the present one indicated that: i) this condition mainly affects middle-aged females; ii) the main symptom is abdominal or back pain, or no symptoms; iii) a hormone production symptom was observed in only one case; iv) the most common degree of dysplasia of IPMN is low grade; and v) the size of the NET is not particularly large (average 15.1 mm), although the clinical behavior is not always indolent (metastasis was observed in 3 cases). It is well known that IPMNs are associated with a high incidence of extrapancreatic malignancies, including colorectal and gastric carcinomas. Concomitant pancreatic NET and extrapancreatic malignancies may occur, therefore, systemic surveillance of extrapancreatic neoplasms and detection of concomitant NETs of the pancreas are necessary for patients with IPMN.

Entities:  

Year:  2012        PMID: 23255895      PMCID: PMC3525483          DOI: 10.3892/ol.2012.952

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  15 in total

1.  Immunohistochemical demonstration of the type III intermediate filament peripherin in human rectal mucosae and well-differentiated endocrine neoplasms.

Authors:  Mitsuaki Ishida; Ryoji Kushima; Tokuhiro Chano; Hidetoshi Okabe
Journal:  Oncol Rep       Date:  2007-09       Impact factor: 3.906

Review 2.  The role of somatostatin and its analogs in the diagnosis and treatment of tumors.

Authors:  S W Lamberts; E P Krenning; J C Reubi
Journal:  Endocr Rev       Date:  1991-11       Impact factor: 19.871

3.  Endocrine tumor and intraductal papillary mucinous neoplasm of the pancreas: a fortuitous association?

Authors:  Frédéric Marrache; Dominique Cazals-Hatem; Reza Kianmanesh; Laurent Palazzo; Anne Couvelard; Dermot O'Toole; Frédérique Maire; Pascal Hammel; Philippe Levy; Alain Sauvanet; Philippe Ruszniewski
Journal:  Pancreas       Date:  2005-07       Impact factor: 3.327

4.  Nesidioblastosis coexisting with islet cell tumor and intraductal papillary mucinous hyperplasia.

Authors:  X Zhao; B E Stabile; J Mo; J Wang; S W French
Journal:  Arch Pathol Lab Med       Date:  2001-10       Impact factor: 5.534

5.  Clinicopathological features of patients with concomitant intraductal papillary mucinous neoplasm of the pancreas and pancreatic endocrine neoplasm.

Authors:  Brian K P Goh; London L P J Ooi; Marian Priyanthi Kumarasinghe; Yu-Meng Tan; Peng-Chung Cheow; Pierce K H Chow; Yaw-Fui Alexander Chung; Wai-Keong Wong
Journal:  Pancreatology       Date:  2006-11-23       Impact factor: 3.996

6.  Somatostatin receptor type 2A immunohistochemistry in neuroendocrine tumors: a proposal of scoring system correlated with somatostatin receptor scintigraphy.

Authors:  Marco Volante; Maria Pia Brizzi; Antongiulio Faggiano; Stefano La Rosa; Ida Rapa; Anna Ferrero; Gelsomina Mansueto; Luisella Righi; Silvana Garancini; Carlo Capella; Gaetano De Rosa; Luigi Dogliotti; Annamaria Colao; Mauro Papotti
Journal:  Mod Pathol       Date:  2007-09-14       Impact factor: 7.842

7.  Synchronous and metachronous extrapancreatic malignant neoplasms in patients with intraductal papillary-mucinous neoplasm of the pancreas.

Authors:  Masaharu Ishida; Shinichi Egawa; Kei Kawaguchi; Takeshi Aoki; Naoaki Sakata; Yukio Mikami; Fuyuhiko Motoi; Tadayoshi Abe; Shoji Fukuyama; Yu Katayose; Makoto Sunamura; Michiaki Unno; Takuya Moriya; Akira Horii; Toru Furukawa
Journal:  Pancreatology       Date:  2008-09-29       Impact factor: 3.996

8.  Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group.

Authors:  Anja Rinke; Hans-Helge Müller; Carmen Schade-Brittinger; Klaus-Jochen Klose; Peter Barth; Matthias Wied; Christina Mayer; Behnaz Aminossadati; Ulrich-Frank Pape; Michael Bläker; Jan Harder; Christian Arnold; Thomas Gress; Rudolf Arnold
Journal:  J Clin Oncol       Date:  2009-08-24       Impact factor: 44.544

9.  Pancreatic neuroendocrine tumors among patients with intraductal papillary mucinous neoplasms: real association or just a coincidence?

Authors:  Kanwar Rupinder S Gill; Daniela Scimeca; John Stauffer; Murli Krishna; Timothy A Woodward; Laith H Jamil; Michael B Wallace; Justin H Nguyen; Massimo Raimondo
Journal:  JOP       Date:  2009-09-04

Review 10.  Management of intraductal papillary mucinous neoplasm of the pancreas.

Authors:  Masanori Sugiyama; Yutaka Suzuki; Nobutsugu Abe; Toshiyuki Mori; Yutaka Atomi
Journal:  J Gastroenterol       Date:  2008-03-29       Impact factor: 7.527

View more
  7 in total

1.  Pathologic Evaluation and Reporting of Intraductal Papillary Mucinous Neoplasms of the Pancreas and Other Tumoral Intraepithelial Neoplasms of Pancreatobiliary Tract: Recommendations of Verona Consensus Meeting.

Authors:  Volkan Adsay; Mari Mino-Kenudson; Toru Furukawa; Olca Basturk; Giuseppe Zamboni; Giovanni Marchegiani; Claudio Bassi; Roberto Salvia; Giuseppe Malleo; Salvatore Paiella; Christopher L Wolfgang; Hanno Matthaei; G Johan Offerhaus; Mustapha Adham; Marco J Bruno; Michelle D Reid; Alyssa Krasinskas; Günter Klöppel; Nobuyuki Ohike; Takuma Tajiri; Kee-Taek Jang; Juan Carlos Roa; Peter Allen; Carlos Fernández-del Castillo; Jin-Young Jang; David S Klimstra; Ralph H Hruban
Journal:  Ann Surg       Date:  2016-01       Impact factor: 12.969

2.  The clinical utility of a novel blood-based multi-transcriptome assay for the diagnosis of neuroendocrine tumors of the gastrointestinal tract.

Authors:  I M Modlin; M Kidd; L Bodei; I Drozdov; H Aslanian
Journal:  Am J Gastroenterol       Date:  2015-06-02       Impact factor: 10.864

Review 3.  Increased risk of second malignancy in pancreatic intraductal papillary mucinous tumors: Review of the literature.

Authors:  Gian Luca Baiocchi; Sarah Molfino; Barbara Frittoli; Graziella Pigozzi; Federico Gheza; Giacomo Gaverini; Antonio Tarasconi; Chiara Ricci; Francesco Bertagna; Luigi Grazioli; Guido A M Tiberio; Nazario Portolani
Journal:  World J Gastroenterol       Date:  2015-06-21       Impact factor: 5.742

Review 4.  Synchronous pancreatic solid pseudopapillary neoplasm and intraductal papillary mucinous neoplasm.

Authors:  Kenichi Hirabayashi; Giuseppe Zamboni; Hiroyuki Ito; Masami Ogawa; Yoshiaki Kawaguchi; Tomohiro Yamashita; Toshio Nakagohri; Naoya Nakamura
Journal:  World J Gastroenterol       Date:  2013-06-07       Impact factor: 5.742

Review 5.  Collision of ductal adenocarcinoma and neuroendocrine tumor of the pancreas: a case report and review of the literature.

Authors:  Simone Serafini; Gianfranco Da Dalt; Gioia Pozza; Stella Blandamura; Michele Valmasoni; Stefano Merigliano; Cosimo Sperti
Journal:  World J Surg Oncol       Date:  2017-05-02       Impact factor: 2.754

Review 6.  The clinical applications of a multigene liquid biopsy (NETest) in neuroendocrine tumors.

Authors:  Anna Malczewska; Beata Kos-Kudła; Mark Kidd; Ignat Drozdov; Lisa Bodei; Somer Matar; Kjell Oberg; Irvin M Modlin
Journal:  Adv Med Sci       Date:  2019-12-13       Impact factor: 3.287

Review 7.  Case report: composite pancreatic intraductal papillary mucinous neoplasm and neuroendocrine tumor: a new mixed neuroendocrine-non-neuroendocrine neoplasm?

Authors:  Jingci Chen; Pengyan Wang; Ke Lv; Weixun Zhou
Journal:  Diagn Pathol       Date:  2021-11-20       Impact factor: 2.644

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.